178 related articles for article (PubMed ID: 15047206)
21. Use of number needed to treat in cost-effectiveness analyses.
Garg V; Shen X; Cheng Y; Nawarskas JJ; Raisch DW
Ann Pharmacother; 2013 Mar; 47(3):380-7. PubMed ID: 23463742
[TBL] [Abstract][Full Text] [Related]
22. [Methodology of economic assessment: example in oncology].
Jaisson-Hot I; Schott AM; Clippe C; Ganne C; Hajri T; Poncet B; Trillet-Lenoir V; Colin C
Bull Cancer; 2003 Nov; 90(11):939-45. PubMed ID: 14706896
[TBL] [Abstract][Full Text] [Related]
23. Economic analyses in obstetrics and gynecology: a methodologic evaluation of the literature.
Smith WJ; Blackmore CC
Obstet Gynecol; 1998 Mar; 91(3):472-8. PubMed ID: 9491880
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Health Economics in Radiation Oncology: A Systematic Review.
Nguyen TK; Goodman CD; Boldt RG; Warner A; Palma DA; Rodrigues GB; Lock MI; Mishra MV; Zaric GS; Louie AV
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1006-14. PubMed ID: 26883562
[TBL] [Abstract][Full Text] [Related]
25. [Studies of cost-effectiveness and cost-usefulness in radiology].
Janne d'Othée B; Bettmann MA; Pirard S; Zhuang Z; Black WC
J Radiol; 2001 Dec; 82(12 Pt 1):1687-92. PubMed ID: 11917633
[TBL] [Abstract][Full Text] [Related]
26. Accuracy of terminology and methodology in economic analyses in otolaryngology.
Kezirian EJ; Yueh B
Otolaryngol Head Neck Surg; 2001 May; 124(5):496-502. PubMed ID: 11337651
[TBL] [Abstract][Full Text] [Related]
27. Improving quality and decreasing cost in gynecologic oncology care. Society of gynecologic oncology recommendations for clinical practice.
Rimel BJ; Burke WM; Higgins RV; Lee PS; Lutman CV; Parker L
Gynecol Oncol; 2015 May; 137(2):280-4. PubMed ID: 25735256
[TBL] [Abstract][Full Text] [Related]
28. Methodologic quality of cost-effectiveness analyses of surgical procedures.
Kruper L; Kurichi JE; Sonnad SS
Ann Surg; 2007 Jan; 245(1):147-51. PubMed ID: 17197978
[TBL] [Abstract][Full Text] [Related]
29. Quality assessment of economic analyses of pharmacological and nutritional therapy for hyperlipidemia.
Kumar RN; Raisch DW; Borrego ME
Expert Rev Pharmacoecon Outcomes Res; 2002 Dec; 2(6):565-75. PubMed ID: 19807481
[TBL] [Abstract][Full Text] [Related]
30. Methodologic evaluation of the radiology cost-effectiveness literature.
Blackmore CC; Magid DJ
Radiology; 1997 Apr; 203(1):87-91. PubMed ID: 9122421
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness considerations in critical care.
Rubenfeld GD
New Horiz; 1998 Feb; 6(1):33-40. PubMed ID: 9508256
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness analysis for clinical procedures in oncology.
Weinstein MC
Bull Cancer; 1980; 67(5):491-500. PubMed ID: 6783150
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness analysis based on the number-needed-to-treat: common sense or non-sense?
Kristiansen IS; Gyrd-Hansen D
Health Econ; 2004 Jan; 13(1):9-19. PubMed ID: 14724890
[TBL] [Abstract][Full Text] [Related]
34. [Economic analyses of health care. Cost benefit analyses promote better use of resources].
Kristiansen IS
Tidsskr Nor Laegeforen; 1990 Aug; 110(18):2377-81. PubMed ID: 2120789
[TBL] [Abstract][Full Text] [Related]
35. [How effective is the teaching of critical analysis of scientific publications? Review of studies and their methodological quality].
Audet N; Gagnon R; Ladouceur R; Marcil M
CMAJ; 1993 Mar; 148(6):945-52. PubMed ID: 8448709
[TBL] [Abstract][Full Text] [Related]
36. Practical feasibility of outcomes research in oncology: lessons learned in assessing drug use and cost-effectiveness in The Netherlands.
Franken MG; van Gils CW; Gaultney JG; Delwel GO; Goettsch W; Huijgens PC; Steenhoek A; Punt CJ; Koopman M; Redekop WK; Uyl-de Groot CA
Eur J Cancer; 2013 Jan; 49(1):8-16. PubMed ID: 22809557
[TBL] [Abstract][Full Text] [Related]
37. [Methodological quality of articles on therapeutic procedures published in Cirugía Española. Evaluation of the period 2005-2008].
Manterola C; Grande L
Cir Esp; 2010 Apr; 87(4):244-50. PubMed ID: 20079489
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness analysis: what is it and how will it influence neurology.
Holloway RG
Ann Neurol; 1996 Jun; 39(6):818-23. PubMed ID: 8651658
[TBL] [Abstract][Full Text] [Related]
39. [Cancer and health economics].
Koinuma N
Gan To Kagaku Ryoho; 1996 Jan; 23(1):1-7. PubMed ID: 8546457
[TBL] [Abstract][Full Text] [Related]
40. Systematic overview of cost-utility assessments in oncology.
Earle CC; Chapman RH; Baker CS; Bell CM; Stone PW; Sandberg EA; Neumann PJ
J Clin Oncol; 2000 Sep; 18(18):3302-17. PubMed ID: 10986064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
